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The Editorial on the Research Topic
Linking Hypoxia to Obesity
Obesity is a major public health problem that constitutes a worldwide epidemic, often associated 
with metabolic and cardiovascular diseases, and some types of cancers (1). The rising prevalence of 
obesity and obesity-related medical conditions has therefore promoted much interest and research 
on the role of adipose tissue, previously seen simply as an inert lipid storage site. In the last two 
decades, many biologically active molecules produced by fat have been identified, evoking a role 
of this tissue in previously unsuspected processes, including inflammation, insulin, and glucose 
homeostasis, angiogenesis, and hemostasis (2). Hormonal factors produced by adipose cells have 
been collectively called “adipokines”, and include about a hundred of known molecules, such as 
leptin, adiponectin, resistin, apelin, visfatin, VEGF, PAI-1, and many other, not yet identified 
factors, that have recently emerged by proteomic strategies (3, 4). It has been postulated that the 
adipose tissue of the obese, becoming dysfunctional by changes in the secretion pattern of adi-
pokines, may sustain inflammation, insulin resistance, and a pro-thrombotic state with endothe-
lial dysfunction, all conditions underpinning obesity-related comorbidities (5, 6). The notion of 
obesity as a systemic, low-grade inflammatory state promoting insulin resistance has become 
commonly accepted (7), although the event(s) and the related molecular mechanisms that initially 
trigger adipose tissue dysfunction have remained still poorly characterized. In this regard, a direct 
role of hypoxia in adipose and non-adipose cells in fat tissue has been demonstrated both in vivo, 
in animal models, and in in vitro studies (8–11). Oxidative stress, endoplasmic reticulum stress, 
and the activation of the unfolded protein response can represent additional cellular processes, 
indirectly linked to hypoxia, which may operate in hypertrophic fat cells.
The aim of this research topic was to provide insights into the mechanisms triggered by hypoxia 
in obesity.
Hypoxia-inducible factor 1 (HIF-1) is considered the main nuclear transcription factor that medi-
ates cellular response to low oxygen tension (12). Although the scenario is far from be complete, 
many HIF-1-inducible genes have been identified in the adipose tissue, including leptin, VEGF, 
GLUT1, metalloproteinases MMP2 and MMP9, IL-4, IL-6, and PAI-1, thereby implicating a role 
of hypoxia in important processes, such as inflammation, insulin resistance and glucose intoler-
ance, and angiogenesis (9, 13, 14). In this context, the molecular interplay between HIF-1 and other 
nuclear partners involved in the gene networks affected by oxygen availability (i.e., NF-κB, HIF-2, 
CREB, PPARγ) deserves further investigation.
Messineo et al. contributed a research article on the physical and functional interaction between 
HIF-1 and HMGA1, two factors that share important roles in adipose tissue and inflammation. 
Using in vitro differentiated 3T3-L1 adipocytes, cooperation between HIF-1 and HMGA1 proteins 
was demonstrated for the first time in the transcriptional activation of the hypoxia-responsive Vegf 
and visfatin genes, suggesting that HMGA1 may represent a novel nuclear partner of HIF-1, thereby 
serving as a modulator of HIF-1 activity in hypoxia. A more detailed analysis of the molecular 
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cross-talk between these two factors may help identifying protein 
and gene networks relevant to obesity.
A plethora of studies using transgenic models have addressed 
the role of the HIFs on adipose dysfunction (15–18). Although 
findings are complex to interpret and sometimes contradictory, 
evidences exist that the HIF pathway does contribute to the obese 
phenotypes.
Lin and Yun reviewed the role of HIF-2 in hypertrophic cardio-
myopathy, a condition that may occur in obesity independently 
of other cardiovascular risk factors, including hypertension, 
diabetes, and coronary heart disease. The Authors drew attention 
to the fact that stabilization of HIF-2, as obtained in genetically 
engineered mice, is followed by fat inflammation and lethal car-
diomegaly, pointing to a novel pathophysiological role of HIF-2 
in driving NF-κB and NFAT activation, that may ultimately 
compromise heart development, morphology, and function.
Goossens and Blaak focused into the controversial relevance 
of oxygen in human obesity and delineated future directions. 
Starting from the consolidated notion that adipose tissue hypoxia 
plays an important role in adipose dysfunction in mouse models 
of obesity, the Authors summarized current findings in human 
obesity, underlining how methodological differences may 
account for discrepant results (i.e., measurements of adipose tis-
sue oxygen partial pressure and metabolic markers). Accordingly, 
advancements are expected from studies in progress with obese 
patients before and after weight loss and from techniques that 
allow for a better characterization of the degree, severity, and 
pattern of hypoxia.
Heinonen et al. reviewed the effects of hypoxia and the conse-
quent physiological adaptation to altitude exposure and physical 
exercise, in terms of cardiovascular and metabolic responses. 
While focusing on conditions implicating hypoxia in adipose 
tissue during rest and moderate or intense exercise, the Authors 
discussed the mechanisms that influence adipose tissue blood 
flow in each condition and considered the positive and negative 
consequences of hypoxia and hyperoxia in relation to treatment 
of obesity.
The effects of hypoxia on the different adipose tissue depots 
(white, brown, and brite) were discussed in a paper by Trayhurn 
and Alomar, where Authors focused also on the less explored 
brown adipose tissue, in which reduced oxygen tension in obese 
mice leads to whitening of brown fat and mitochondrial loss 
and dysfunction. They hypothesized that, as in white adipose 
tissue, oxygen deprivation in brown fat may trigger changes in 
adipokine secretion, increase glucose uptake and lactate release, 
reduce free fatty acid uptake, and promote fibrosis and insulin 
resistance, thus contributing to the development of the metabolic 
syndrome. In an emerging complex scenario, as a consequence 
of obesity and hypoxia, the production of lactate by anaerobic 
metabolism in the white adipose tissue (19), through the stimula-
tion of UCP1, promotes thermogenesis via lipid oxidation and 
the development of brite cells within white depots, leading to 
browning of white fat.
In summary, these articles have contributed importantly to 
the current debate linking hypoxia to obesity. Our hope is that 
a better understanding of the role of hypoxia in adipose tissue 
will contribute to deepen our knowledge on the pathophysiology 
of obesity and obesity-related disorders, leading to innovative 
targets for preventive and therapeutic interventions.
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